Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
- PMID: 28754951
- PMCID: PMC5533777
- DOI: 10.1038/s41598-017-06680-4
Mass spectrometry-based determination of Kallikrein-related peptidase 7 (KLK7) cleavage preferences and subsite dependency
Abstract
The cleavage preferences of Kallikrein-related peptidase 7 (KLK7) have previously been delineated using synthetic peptide libraries of fixed length, or single protein chains and have suggested that KLK7 exerts a chymotryptic-like cleavage preference. Due to the short length of the peptides utilised, only a limited number of subsites have however been assessed. To determine the subsite preferences of KLK7 in a global setting, we used a mass spectrometry (MS)-based in-depth proteomics approach that utilises human proteome-derived peptide libraries of varying length, termed Proteomic Identification of protease Cleavage Sites (PICS). Consistent with previous findings, KLK7 was found to exert chymotryptic-like cleavage preferences. KLK7 subsite preferences were also characterised in the P2-P2' region, demonstrating a preference for hydrophobic residues in the non-prime and hydrophilic residues in the prime subsites. Interestingly, single catalytic triad mutant KLK7 (mKLK7; S195A) also showed residual catalytic activity (kcat/KM = 7.93 × 102 s-1M-1). Catalytic inactivity of KLK7 was however achieved by additional mutation in this region (D102N). In addition to characterising the cleavage preferences of KLK7, our data thereby also suggests that the use of double catalytic triad mutants should be employed as more appropriate negative controls in future investigations of KLK7, especially when highly sensitive MS-based approaches are employed.
Conflict of interest statement
The authors declare that they have no competing interests.
Figures




Similar articles
-
Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.Mol Cell Proteomics. 2019 May;18(5):818-836. doi: 10.1074/mcp.RA118.001304. Epub 2019 Jan 31. Mol Cell Proteomics. 2019. PMID: 30705123 Free PMC article.
-
Specificity studies on Kallikrein-related peptidase 7 (KLK7) and effects of osmolytes and glycosaminoglycans on its peptidase activity.Biochim Biophys Acta. 2015 Jan;1854(1):73-83. doi: 10.1016/j.bbapap.2014.10.018. Epub 2014 Oct 30. Biochim Biophys Acta. 2015. PMID: 25448018
-
Novel Biological Substrates of Human Kallikrein 7 Identified through Degradomics.J Biol Chem. 2015 Jul 17;290(29):17762-17775. doi: 10.1074/jbc.M115.643551. Epub 2015 Jun 1. J Biol Chem. 2015. PMID: 26032414 Free PMC article.
-
Structures and specificity of the human kallikrein-related peptidases KLK 4, 5, 6, and 7.Biol Chem. 2008 Jun;389(6):623-32. doi: 10.1515/BC.2008.075. Biol Chem. 2008. PMID: 18627343 Review.
-
The Role of Kallikrein 7 in Tumorigenesis.Curr Med Chem. 2022;29(15):2617-2631. doi: 10.2174/0929867328666210915104537. Curr Med Chem. 2022. PMID: 34525904 Review.
Cited by
-
Integration of Two In-depth Quantitative Proteomics Approaches Determines the Kallikrein-related Peptidase 7 (KLK7) Degradome in Ovarian Cancer Cell Secretome.Mol Cell Proteomics. 2019 May;18(5):818-836. doi: 10.1074/mcp.RA118.001304. Epub 2019 Jan 31. Mol Cell Proteomics. 2019. PMID: 30705123 Free PMC article.
-
Prognostic value of kallikrein-related peptidase 7 (KLK7) mRNA expression in advanced high-grade serous ovarian cancer.J Ovarian Res. 2020 Oct 21;13(1):125. doi: 10.1186/s13048-020-00725-5. J Ovarian Res. 2020. PMID: 33087135 Free PMC article.
References
-
- Yousef GM, Scorilas A, Magklara A, Soosaipillai A, Diamandis EP. The KLK7 (PRSS6) gene, encoding for the stratum corenum chymotryptic enzyme is a new member of the human kallikrein gene family-genome characterization, mapping, tissue expression and hormonal regulation. Gene. 2000;254:119–128. doi: 10.1016/S0378-1119(00)00280-8. - DOI - PubMed
-
- Clements J. The molecular biology of the kallikreins and their roles in inflammation. The kinin system. 1997;5:71–97. doi: 10.1016/B978-012249340-9/50007-3. - DOI
-
- Dong Y, Kaushal A, Brattsand M, Nicklin J, Clements JA. Differential Splicing of KLK5 and KLK7 in Epithelial Ovarian Cancer Produces Novel Varients with Potential as Cancer Biomarkers. Clinical Cancer Research. 2003;9:1710–1720. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous